When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

6.10.2024

Haemo Pharma & WINBACK: Live at the Erste Bank Open 2024!

From October 19 to 27, the world's best tennis players will be competing for the title in the prestigious ATP 500 tournament at the Wiener Stadthalle. Hämo Pharma is pleased to once again be an official partner of the Erste Bank Open.

Überblick über die volle Zuschauertribüne der Erste Bank Open 2024 in der Wiener Stadthalle, mit Haemo Pharma-Logo und ATP 500-Branding im Vordergrund

WINBACK Back4: The secret tip for tennis professionals

Innovative is at the heart of our local activities WINBACK Back 4. With its patented multi-frequency technology, it accelerates regeneration and promotes healing processes. During the Erste Bank Open, these devices are available to ATP physiotherapists to optimally prepare athletes and help them recover. In this way, our devices make a decisive contribution to keeping players fit and exploiting their full performance potential.

Optimum performance on the pitch

The WINBACK Back4 specifically stimulates muscles, tendons, joints and fascia and improves blood circulation and lymph flow — essential factors for the various movements and strains in tennis. This innovative therapy enables players to quickly treat acute injuries and effectively address chronic complaints and post-operative rehabilitation processes.

We are looking forward to exciting matches and unforgettable moments during the tournament!

Learn more about WINBACK

Für weitere Informationen kontaktieren Sie bitte:

More posts

Product Update

Long-term study proves lasting success with HyaloFast

A recent long-term study (Whyte et al. 2024) confirms the sustainable effectiveness of HyaloFast.
Sponsoring

Haemo Pharma as ADMIRA Wacker's new healthcare partner

Hämo Pharma is pleased to announce its partnership with the traditional soccer club ADMIRA Wacker.
Product Presentation

Stem cell therapy for degenerative joint diseases

In an Ö24 interview, Prof. Dr. Zimpfer provides insights into stem cell therapy and new approaches .

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.